Newborn Screening identifies conditions that can affect a child's long-term health or survival. CDC's Newborn Screening and Molecular Biology Branch manages the Newborn Screening Quality Assurance Program (NSQAP) to enhance and maintain the quality and accuracy of newborn screening results. The program provides training, consultation, guidelines, and dried blood spot proficiency testing and quality control materials to state public health laboratories and other laboratories responsible for newborn screening in the U.S. and many other countries.
A2LA Accredited PT Provider
CDC's Newborn Screening and Molecular Biology Branch (NSMBB) has been granted ISO/IEC 17043 accrediation by the American Association for Laboratory Accreditation (A2LA). Please consult A2LA Certification #4190.01 for a list of accrediated NSMBB proficiency testing programs.
